Screener
Asset Entities ASST Medical Device — General and administrative expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Asset Entities in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: Asset Entities’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054985
| Line item | Successor / Three Months Ended June 30, 2026 | Predecessor / Three Months Ended June 30, 2025 |
|---|---|---|
| Operating expenses: | ||
| Fund management and administration | 1,489 | 1,588 |
| Employee compensation and benefits | 16,314 | 2,005 |
| General and administrative expense | 6,428 | 1,452 |
| Marketing and advertising | 79 | 102 |
| Depreciation and amortization | 86 | 54 |
| Total operating expenses | 24,396 | 5,201 |
| Investment losses: |
Item 1. Consolidated Financial Statements
FAQ
- What is Asset Entities's medical device — general and administrative expense?
- Asset Entities (ASST) reported medical device — general and administrative expense of $2.9M in Q2 2026.
- What does medical device — general and administrative expense mean?
- This includes the indirect costs necessary to support the daily operations of the business segment, excluding direct production or sales costs. It encompasses items such as office overhead, professional fees, and administrative support services. Controlling these expenses is critical for maintaining the segment's overall profitability margins.
Ask your AI about Asset Entities's medical device — general and administrative expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude